Ivy D D, Ziegler J W, Dubus M F, Fox J J, Kinsella J P, Abman S H
Sections of Cardiology, University of Colorado School of Medicine, Denver 80218, USA.
Pediatr Res. 1996 Mar;39(3):435-42. doi: 10.1203/00006450-199603000-00010.
Although endothelin (ET) contributes to the regulation of pulmonary vascular tone in the normal fetus, little is known about its role in pulmonary hypertension in the perinatal period. To examine the role of the ETB receptor in the normal ovine fetal lung, we studied the hemodynamic effects of ET-3 (a selective ETB receptor agonist) before and after RES-701 (a selective ETB receptor antagonist). RES-701 (10 mu g/min for 10 min) did not change basal pulmonary tone and blocked pulmonary vasodilation to ET-3 (500 ng/min for 10 min). To examine the effects of experimental perinatal pulmonary hypertension on activity of the ETA and ETB receptors, we studied the hemodynamic effects of ET-3, ET-1 (a nonselective ETA and ETB receptor agonist), and BQ 123 (a selective ETA receptor antagonist) in 12 chronically prepared late gestation fetal lambs after partial ligation of the ductus arteriosus. Serial changes in the pulmonary vascular effects of these agents were measured early (1-3 d) and late (7-10 d) after partial ductus arteriosus ligation. Left lung total pulmonary resistance in the normal late-gestation fetus was 0.62 +/- 0.01 mm Hg/ml/min (n = 4). After partial ductus arteriosus ligation, total pulmonary resistance increased to 1.2 +/- 0.3 (early; p < 0.05 versus normal), and progressively rose to 1.9 +/- 0.2 mm Hg/ml/min (late; p < 0.05 versus early). Intrapulmonary infusion of ET-3 (500 ng/min for 10 min) increased pulmonary blood flow from 94 +/- 11 to 183 +/- 17 mL/min in the normal fetus, but had no effect during late pulmonary hypertension. Infusions of ET-1 (50 ng/min for 30 min) caused transient pulmonary vasodilation followed by vasoconstriction during early pulmonary hypertension. During late pulmonary hypertension, however, infusion of ET-1 caused predominantly vasoconstriction. Pulmonary vasodilation to BQ 123 (100 mu g/min for 10 min) was greater during late than early pulmonary hypertension (43 versus 21%; p < 0.05). After 10 d of ductus arteriosus ligation, immunoreactive ET-1 content in whole lung tissue was 3-fold higher in hypertensive (n = 7) than control (n = 10) lungs (p < 0.05). We conclude that the ETB receptor contributes little to regulation of basal vascular tone in the normal ovine fetal lung and that chronic intrauterine pulmonary hypertension causes the loss of ETB-mediated vasodilation, progressive ETA-mediated vasoconstriction, and increased lung ET-1 content. We speculate that diminished ETB receptor-mediated vasodilation in combination with enhanced ETA receptor-mediated vasoconstriction and increased ET-1 production contributes to high pulmonary vascular resistance in perinatal pulmonary hypertension.
尽管内皮素(ET)在正常胎儿中有助于调节肺血管张力,但关于其在围产期肺动脉高压中的作用知之甚少。为了研究ETB受体在正常绵羊胎儿肺中的作用,我们在给予RES-701(一种选择性ETB受体拮抗剂)前后,研究了ET-3(一种选择性ETB受体激动剂)的血流动力学效应。RES-701(10μg/分钟,持续10分钟)未改变基础肺张力,并阻断了对ET-3(500 ng/分钟,持续10分钟)的肺血管舒张反应。为了研究实验性围产期肺动脉高压对ETA和ETB受体活性的影响,我们在12只慢性制备的妊娠晚期胎儿羔羊动脉导管部分结扎后,研究了ET-3、ET-1(一种非选择性ETA和ETB受体激动剂)和BQ 123(一种选择性ETA受体拮抗剂)的血流动力学效应。在动脉导管部分结扎后的早期(1 - 3天)和晚期(7 - 10天),测量了这些药物肺血管效应的系列变化。正常妊娠晚期胎儿的左肺总肺阻力为0.62±0.01 mmHg/ml/分钟(n = 4)。动脉导管部分结扎后,总肺阻力增加至1.2±0.3(早期;与正常相比,p < 0.05),并逐渐升至1.9±0.2 mmHg/ml/分钟(晚期;与早期相比,p < 0.05)。在正常胎儿中,肺内输注ET-3(500 ng/分钟,持续10分钟)使肺血流量从94±11增加至183±17 ml/分钟,但在晚期肺动脉高压期间无作用。在早期肺动脉高压期间,输注ET-1(50 ng/分钟,持续30分钟)引起短暂的肺血管舒张,随后是血管收缩。然而,在晚期肺动脉高压期间,输注ET-1主要引起血管收缩。在晚期肺动脉高压期间,对BQ 123(100μg/分钟,持续10分钟)的肺血管舒张作用大于早期(43%对21%;p < 0.05)。动脉导管结扎10天后,高血压组(n = 7)全肺组织中免疫反应性ET-1含量比对照组(n = 10)高3倍(p < 0.05)。我们得出结论,ETB受体对正常绵羊胎儿肺基础血管张力的调节作用很小,慢性宫内肺动脉高压导致ETB介导的血管舒张丧失、ETA介导的血管收缩逐渐增强以及肺ET-1含量增加。我们推测,ETB受体介导的血管舒张减弱,与ETA受体介导的血管收缩增强和ET-1产生增加相结合,导致围产期肺动脉高压时肺血管阻力升高。